MedTrace Logo

Management of LUTS by Community Pharmacists

NCT04331340 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-09-20

No results posted yet for this study

Summary

Many older adults have urinary incontinence. They often seek treatments, such as diapers, pads, or medications, from the community pharmacy. Pharmacists are trained to assist seniors with therapies that treat urinary incontinence. Our study will determine how much benefit there is if pharmacists try to provide more assistance for seniors with incontinence. Over a period of months, half of the people who talk to the pharmacist about their incontinence will be given general information about health and aging. The other half of the people will have a longer assessment and complete a questionnaire with the pharmacist. Then the pharmacist will call and have a follow-up visit to see how the incontinence symptoms have improved. We will compare both groups to see whose symptoms were improved.

Conditions

  • Lower Urinary Tract Symptoms

Interventions

OTHER

Pharmacist review of LUTS

Pharmacist review and recommendations, including education, behaviour, lifestyle, or medications

OTHER

Pharmacist Provision of healthy aging leaflets

Pharmacist will inquire about presence of LUTS and provide patient with healthy aging leaflets

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • University of Alberta

    lead OTHER

Principal Investigators

  • Cheryl A Sadowski, Pharm.D. · University of Alberta

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-26
Primary Completion
2024-06-30
Completion
2024-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04331340 on ClinicalTrials.gov